QUESTLAB — Quest Laboratories Balance Sheet
0.000.00%
- IN₹1.42bn
- IN₹1.24bn
- IN₹1.04bn
- 35
- 69
- 37
- 44
Annual balance sheet for Quest Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4.16 | 15.7 | 25 | 1.44 | 493 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 107 | 241 | 224 | 235 | 309 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 121 | 268 | 361 | 416 | 1,069 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 59.4 | 73.8 | 98.4 | 102 | 118 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 184 | 348 | 466 | 593 | 1,216 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 110 | 229 | 288 | 287 | 372 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 125 | 248 | 316 | 306 | 398 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 58.9 | 99.9 | 150 | 286 | 818 |
| Total Liabilities & Shareholders' Equity | 184 | 348 | 466 | 593 | 1,216 |
| Total Common Shares Outstanding |